Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

How an experimental Alzheimer’s drug could also be effective for antibiotic resistance

Staff Writer
Staff Writer 5 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

One of the greatest ongoing difficulties in the medical community continues to be bacterial resistance to antibiotics. In a study by the University of Queensland, the University of Melbourne, and Griffith University, their experimentation on a purported treatment for Alzheimer’s disease has shown promise for antibiotic resistance.

According to the findings, released in Science Translational Medicine, the experimental treatment of Alzheimer’s disease, known as PBT2, was determined to be effective at eliminating a form of bacteria called Gram-negative bacteria, common in cases of pneumonia.

“The emergence of antibiotic-resistant superbugs is an urgent threat to human health, undermining the capacity to treat patients with serious infection,” a press release of the findings states.

“Led by UQ’s Dr. David De Oliveira, our team hypothesised that, by using this experimental Alzheimer’s treatment to disrupt the metals inside these bacteria, we would also disrupt their mechanisms of antibiotic resistance.”

Researchers determined, based on studies of rodents, that the experimental Alzheimer’s drug was effective at eliminating polymyxin-resistant bacteria when used in combination with polymyxin.

Overall, the findings of this experimental drug may pave the way for transitioning some in-effective antibiotics into effective drugs for treating infection.

Photo: Biotech Capital

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: bacteria, PBT2, Alzheimer's disease, antibiotics
Staff Writer November 19, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Women living in areas of high air pollution are at an increased risk of dementia
Next Article Researchers fiddle with environmental DNA techniques to improve terrorism probes

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?